# Guilin Pharmaceutical Co., Ltd. – FDA Inspection, Jul 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/guilin-pharmaceutical-co-ltd/b4eb333f-6776-4112-b186-4dad9d53ea0e
Source feed: FDA_Inspections

> FDA inspection 1061489 of Guilin Pharmaceutical Co., Ltd., July 19, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061489
- Company Name: Guilin Pharmaceutical Co., Ltd.
- Inspection Date: 2018-07-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1217732 - 2023-08-18](https://www.keypedia.com/records/fda_inspections/guilin-pharmaceutical-co-ltd/330fef8b-c36c-41fe-beb1-3e7344d42db6)
- FDA Inspection 920262 - 2015-03-13
- FDA Inspection 748950 - 2011-09-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)

Company: https://www.keypedia.com/companies/guilin-pharmaceutical-co-ltd/8a53776f-b81a-417d-b1c5-ea1cd2d0b0a8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c